Annual CFF
$11.32 M
+$5.28 M+87.50%
December 31, 2023
Summary
- As of February 7, 2025, HOTH annual cash flow from financing activities is $11.32 million, with the most recent change of +$5.28 million (+87.50%) on December 31, 2023.
- During the last 3 years, HOTH annual CFF has risen by +$2.59 million (+29.71%).
- HOTH annual CFF is now -37.80% below its all-time high of $18.19 million, reached on December 31, 2021.
Performance
HOTH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
-$3.68 M-100.00%
September 30, 2024
Summary
- As of February 7, 2025, HOTH quarterly cash flow from financing activities is $0.00, with the most recent change of -$3.68 million (-100.00%) on September 30, 2024.
- Over the past year, HOTH quarterly CFF has dropped by -$3.68 million (-100.00%).
- HOTH quarterly CFF is now -100.00% below its all-time high of $18.43 million, reached on March 31, 2021.
Performance
HOTH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$3.68 M
-$2.41 M-39.52%
September 30, 2024
Summary
- As of February 7, 2025, HOTH TTM cash flow from financing activities is $3.68 million, with the most recent change of -$2.41 million (-39.52%) on September 30, 2024.
- Over the past year, HOTH TTM CFF has dropped by -$2.41 million (-39.52%).
- HOTH TTM CFF is now -83.94% below its all-time high of $22.93 million, reached on March 31, 2021.
Performance
HOTH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
HOTH Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +87.5% | -100.0% | -39.5% |
| 3 y3 years | +29.7% | +100.0% | -79.8% |
| 5 y5 years | +880.0% | -100.0% | -50.6% |
HOTH Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.8% | +87.5% | -100.0% | at low | -79.8% | +1655.7% |
| 5 y | 5-year | -37.8% | +87.5% | -100.0% | +100.0% | -83.9% | +1655.7% |
| alltime | all time | -37.8% | +880.0% | -100.0% | +100.0% | -83.9% | +1655.7% |
Hoth Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $3.68 M(-39.5%) |
| Jun 2024 | - | $3.68 M(>+9900.0%) | $6.09 M(+153.0%) |
| Mar 2024 | - | $0.00(0.0%) | $2.41 M(-78.7%) |
| Dec 2023 | $11.32 M(+87.5%) | $0.00(-100.0%) | $11.32 M(-0.4%) |
| Sep 2023 | - | $2.41 M(>+9900.0%) | $11.37 M(+26.8%) |
| Jun 2023 | - | $0.00(-100.0%) | $8.96 M(-40.0%) |
| Mar 2023 | - | $8.91 M(>+9900.0%) | $14.95 M(+147.6%) |
| Dec 2022 | $6.04 M(-66.8%) | $51.00 K(>+9900.0%) | $6.04 M(+0.9%) |
| Sep 2022 | - | $0.00(-100.0%) | $5.99 M(+1.7%) |
| Jun 2022 | - | $5.99 M(>+9900.0%) | $5.89 M(-2586.3%) |
| Mar 2022 | - | $0.00(0.0%) | -$236.70 K(-101.3%) |
| Dec 2021 | $18.19 M | $0.00(-100.0%) | $18.19 M(0.0%) |
| Sep 2021 | - | -$100.00 K(-26.8%) | $18.19 M(-0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$136.70 K(-100.7%) | $18.29 M(-20.2%) |
| Mar 2021 | - | $18.43 M(>+9900.0%) | $22.93 M(+162.7%) |
| Dec 2020 | $8.72 M(+17.1%) | $0.00(0.0%) | $8.73 M(0.0%) |
| Sep 2020 | - | $0.00(-100.0%) | $8.73 M(-15.6%) |
| Jun 2020 | - | $4.49 M(+6.2%) | $10.34 M(+77.5%) |
| Mar 2020 | - | $4.23 M(>+9900.0%) | $5.82 M(-21.8%) |
| Dec 2019 | $7.45 M(+545.2%) | $0.00(-100.0%) | $7.45 M(0.0%) |
| Sep 2019 | - | $1.61 M(-9461.0%) | $7.45 M(+28.3%) |
| Jun 2019 | - | -$17.20 K(-100.3%) | $5.81 M(-0.3%) |
| Mar 2019 | - | $5.86 M(>+9900.0%) | $5.83 M(+404.5%) |
| Dec 2018 | $1.15 M | $0.00(-100.0%) | $1.15 M(0.0%) |
| Sep 2018 | - | -$31.50 K(<-9900.0%) | $1.15 M(-2.7%) |
| Jun 2018 | - | $0.00(-100.0%) | $1.19 M(0.0%) |
| Mar 2018 | - | $1.19 M | $1.19 M |
FAQ
- What is Hoth Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Hoth Therapeutics?
- What is Hoth Therapeutics annual CFF year-on-year change?
- What is Hoth Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Hoth Therapeutics?
- What is Hoth Therapeutics quarterly CFF year-on-year change?
- What is Hoth Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Hoth Therapeutics?
- What is Hoth Therapeutics TTM CFF year-on-year change?
What is Hoth Therapeutics annual cash flow from financing activities?
The current annual CFF of HOTH is $11.32 M
What is the all time high annual CFF for Hoth Therapeutics?
Hoth Therapeutics all-time high annual cash flow from financing activities is $18.19 M
What is Hoth Therapeutics annual CFF year-on-year change?
Over the past year, HOTH annual cash flow from financing activities has changed by +$5.28 M (+87.50%)
What is Hoth Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of HOTH is $0.00
What is the all time high quarterly CFF for Hoth Therapeutics?
Hoth Therapeutics all-time high quarterly cash flow from financing activities is $18.43 M
What is Hoth Therapeutics quarterly CFF year-on-year change?
Over the past year, HOTH quarterly cash flow from financing activities has changed by -$3.68 M (-100.00%)
What is Hoth Therapeutics TTM cash flow from financing activities?
The current TTM CFF of HOTH is $3.68 M
What is the all time high TTM CFF for Hoth Therapeutics?
Hoth Therapeutics all-time high TTM cash flow from financing activities is $22.93 M
What is Hoth Therapeutics TTM CFF year-on-year change?
Over the past year, HOTH TTM cash flow from financing activities has changed by -$2.41 M (-39.52%)